ADAI News & Events
August 1, 2019
UW, ADAI Study Demonstrates Success of LEAD in Reducing Recidivism
King County’s Law Enforcement Assisted Diversion (LEAD) program aims to break the cycle of arrest and incarceration among low-level drug dealers, addicts and prostitutes. In 2015, a review of LEAD by UW’s Harm Reduction Research and Treatment Lab, led by Susan Collins and Seema Clifasefi of HaRRT and Heather Lonczak of the UW Alcohol and Drug Abuse Institute,…
Small Grants for Marijuana Research
ADAI invites applications for research across a broad range of study related to marijuana use, from basic pharmacology to clinical and psychosocial research. Proposals are welcome from a wide variety of disciplines and University departments. These projects may be either up to 7 mo. duration (Option A) or up to 18 months (Option B), without…
July 26, 2019
Methamphetamine in Washington State Symposium, June 2019
The Alcohol and Drug Abuse Institute brought together more than 130 state policy makers, researchers, and leaders in behavioral health, health care, and social services for a symposium on Methamphetamine in Washington: Informing Policy and Research, held June 28, 2019 on the University of Washington campus. The conference began with two individuals who have lived…
July 16, 2019
St. Paul Island, Alaska Hosts Training by ADAI’s Healing of the Canoe Project
In June 2019, a team from the Healing of the Canoe (HOC) project traveled to remote St. Paul Island in the Pribilof Island chain in the Bering Sea in Alaska. Dennis Donovan, PhD and Lisette Austin from ADAI, and Laura Price from the Port Gamble S’Klallam Tribe, were invited by the Traditional Healing and Behavioral…
June 20, 2019
Northwest ATTC’s New Interactive Online Training for Peers About Opioids
The Northwest Addiction Technology and Transfer Center (Northwest ATTC), located at the UW Alcohol & Drug Abuse Institute, is excited to offer a new training product for peer support specialists about opioid use disorder. Supporting Recovery from Opioid Use: A Peer’s Guide to Person-Centered Care is a one-hour, interactive, self-paced course designed to equip peers, care navigators,…
May 30, 2019
ADAI Small Grants Awards for March 2019
ADAI funded three Small Grants for the March 2019 cycle. The goal of the Small Grants Program is to stimulate research at the University of Washington by supporting promising pilot projects which may ultimately be developed into full studies with outside grant support. Congratulations to the recipients! Jessica R. Canning, Graduate Student, Psychology. Peer Groups…
May 6, 2019
ADAI Welcomes New Director Susan Ferguson
Dr. Susan Ferguson was named as the new Director of the Alcohol and Drug Abuse Institute in April, 2019, and officially began her role at ADAI on July 1. “Addiction is a devastating disease with effects that run deep and wide. I’m excited to be part of an institute that is combatting this disease on…
March 18, 2019
Most Syringe Exchange Clients in Washington State Say They Want Help
Researchers from the University of Washington surveyed clients at syringe exchange sites in Washington state in 2015, to understand people’s interest in stopping or reducing their opioid use. They found that most people wanted help, but weren’t getting it, according to a study, published this month in the Journal of Addiction Medicine. Data for the…
More Overdose Deaths are Likely Coming Nationwide. What About Washington State?
A recent article in the journal JAMA Network Open estimates that overdose deaths are going to continue to rise over the next six years nationwide and reach nearly 82,000 people a year by 2025. The study also estimates that by then one and a half million people will be on illicit opioids, such as heroin,…
Everything We Know About Treating Anxiety With Weed
Weed can, for some, cause anxiety. This is one of the best-known bits of cannabis lore, and according to psychologist Susan Stoner, PhD, research consultant at the UW Alcohol & Drug Abuse Institute. Dr. Stoner reviewed the scientific literature on cannabis’s effects on mental health, it’s also one of the most commonly documented adverse effects…
Previous page Next page
